BullFrog AI (BFRG) surges 122% on new commercial agreement with top-5 global pharma

Web Desk March 30, 2026

0 10 2 minutes read

BullFrog AI (BFRG) surges 122% on new commercial agreement with top-5 global pharma

BullFrog AI Holdings, Inc. (BFRG) is up 122.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears driven by BullFrog AI’s announcement of a new commercial agreement with a top-5 global pharmaceutical company to use its platform to identify and prioritize a therapeutic target in major depressive disorder. For a micro-cap name that has recently disclosed Nasdaq listing compliance challenges, a high-profile commercial deal can be interpreted as third-party validation and a potential step toward improved business momentum.

Details:

The company announced a commercial agreement with a top-5 global pharmaceutical company (by 2025 revenue) to apply BullFrog AI’s bfLEAP platform to identify and prioritize novel drug targets for major depressive disorder.

The agreement includes exclusive access to a target candidate, and the work is positioned as supporting the customer’s drug discovery and clinical development program for this indication.

BullFrog AI stated additional details would be provided in a Current Report on Form 8-K to be filed with the SEC.

In a February 2026 Form 8-K, the company disclosed Nasdaq had determined it did not meet the terms of an extension tied to the minimum stockholders’ equity requirement, creating an overhang that today’s news may be helping to offset in investor sentiment.

Sources:

BullFrog AI Investor Relations, U.S. SEC (EDGAR)

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$BFRG Hedge Fund Activity

We have seen 11 institutional investors add shares of $BFRG stock to their portfolio, and 6 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

DRW SECURITIES, LLC added 102,062 shares (+inf%) to their portfolio in Q4 2025, for an estimated $90,100
ANSON FUNDS MANAGEMENT LP removed 80,750 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $71,286
J.W. COLE ADVISORS, INC. removed 22,050 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $30,869
HRT FINANCIAL LP added 18,799 shares (+inf%) to their portfolio in Q4 2025, for an estimated $16,595
GEODE CAPITAL MANAGEMENT, LLC added 17,100 shares (+30.7%) to their portfolio in Q4 2025, for an estimated $15,095
VIRTU FINANCIAL LLC added 15,287 shares (+inf%) to their portfolio in Q4 2025, for an estimated $13,495
UBS GROUP AG added 8,075 shares (+113.8%) to their portfolio in Q4 2025, for an estimated $7,128

To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative’s disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.